BRIEF-Avexis Enters Into Licensing Agreement With Genethon

1 Min Read

March 13 (Reuters) - Avexis Inc:

* AVEXIS ENTERS INTO LICENSING AGREEMENT WITH GENETHON

* AVEXIS INC - GENETHON GRANTED AVEXIS LICENSE TO PATENTS IN U.S., EUROPE AND JAPAN, FOR AAV9 SMN PRODUCT

* AVEXIS - GENETHON ALSO GRANTED AVEXIS IN VIVO GENE THERAPY DELIVERY OF AAV9 VECTOR INTO CNS Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below